• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER - CRIBRIFORM; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER - CRIBRIFORM; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number MF Septal Occluder Cribriform
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Arrhythmia (1721); Bradycardia (1751); Thrombosis/Thrombus (4440)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a patient had junctional rhythm with bradycardia in the immediately after the occluder was implanted and upon removal of the device the occluder was found to be covered in clots.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review, and no device or additional patient information was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The article, "sinus node recovery after explantation of amplatzer septal occluder: a word of caution", was reviewed.The research article presents a case study of a (b)(6) month old boy, who weighed (b)(6) kg.Co-morbidities included duplication of short arm of chromosome 3 and dandy-walker syndrome.The patient underwent hybrid closure of multiple atrial septal defects ii with a 25mm amplatzer cribriform occluder.The atrial septum was multi-fenestrated, with the largest defect measuring 7.5 mm in diameter, and at least 2 other small defects were identified.The patient¿s baseline heart rhythm was sinus.The patient developed persistent junctional rhythm with bradycardia in the immediate post-procedure period.Isoproterenol was used to counteract this bradycardia.Repeat attempts at weaning isoproterenol resulted in recurrence of his bradycardia and persistence of junctional rhythm.The device itself appeared to be in a good position with no residual shunt.Three days after the initial procedure, the patient was taken to the operating room and through a vertical axillary thoracotomy and using normothermic cardiopulmonary bypass, we were able to visualize the device, which appeared to occupy the majority of the right atrium.The device had multiple clots on both its right and left atrial surfaces, which were most likely related to a combination of a slow rhythm and absence of the atrial kick.The device was removed without difficulty, and a bovine pericardial patch was used to close the asds after transforming them into one large defect placed permanent atrial epicardial pacemaker leads in case a permanent pacemaker would be needed later.The patient had an uncomplicated postoperative course, and regained normal sinus rhythm 3 days later.The patient was discharged 10 days after the initial procedure without needing a permanent pacemaker.The article concluded that the avoidance of using large septal occluder devices, discrepant to the size of the atrial cavities of the child, and while sinus node dysfunction is a rare occurrence, removal of the device should be strongly considered if this complication is encountered.(b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER MULTI-FENESTRATED SEPTAL OCCLUDER - CRIBRIFORM
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key14493500
MDR Text Key292593527
Report Number2135147-2022-00309
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010298
UDI-Public00811806010298
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/25/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMF Septal Occluder Cribriform
Device Catalogue Number9-ASD-MF-025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age13 MO
Patient SexMale
Patient Weight6 KG
-
-